Harboyan Syndrome
Abstract
Harboyan syndrome is a degenerative corneal disorder characterized by congenital hereditary endothelial dystrophy along with progressive, post lingual sensorineural hearing loss. We present the case of a 16-year-old female, who came to us for her follow up after surgical correction for bilateral corneal opacities (bilateral keratplasy) and use of hearing aid for SNHL. Her symptoms resolved significantly. Currently, she's living a healthy life after being treated for Harboyan syndrome. Physical examination and laboratory investigations ruled out other causes (eg: Congenital cataracts, Peters anomaly, Sclerocornea) and the diagnosis of Harboyan syndrome was established.
Keywords: Harboyan Syndrome; SNHL; Sensorineural hearing loss; Keratoplasty; CHED; Congenital hereditary endothelial dystrophy
References
Paniagua LM, Dorfman MEKY, Lavinsky L, Sleifer P. Rehabilitation with cochlear implant in patient with harboyan syndrome. Int Arch Otorhinolaryngol. 2013 Oct;17(4):403-6.
_______________________________________________________
Judisch GF, Maumenee IH. Clinical differentiation of recessive congenital hereditary endothelial dystrophy and dominant hereditary endothelial dystrophy. Am J Ophthalmol. 1978 May 1;85(5 I):606-12. _______________________________________________________
Rahi JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet. 2003 Oct 25;362(9393):1359-65.
_______________________________________________________
Desir J, Moya G, Reish O, Van Regemorter N, Deconinck H, David KL, et al. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy. J Med Genet. 2007 May;44(5):322-6.
_______________________________________________________
Bermejo E, MartÃnez-FrÃas ML. Congenital eye malformations: Clinical-epidemiological analysis of 1,124,654 consecutive births in Spain. Am J Med Genet. 1998 Feb 17;75(5):497-504.
_______________________________________________________
Vithana EN, Morgan P, Sundaresan P, Ebenezer ND, Tan DTH, Mohamed MD, et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet. 2006 Jul;38(7):755-7.
_______________________________________________________
Desir J, Abramowicz M. Congenital hereditary endothelial dystrophy with progressive sensorineural deafness (Harboyan syndrome). Vol. 3, Orphanet Journal of Rare Diseases. 2008.
_______________________________________________________
Desir J, Abramowicz M. Congenital hereditary endothelial dystrophy with progressive sensorineural deafness (Harboyan syndrome) [Internet]. Vol. 3, Orphanet Journal of Rare Diseases. 2008 [cited 2020 Apr 18]. p. 28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18922146
_______________________________________________________
Maumenee AE. Congenital hereditary corneal dystrophy. Am J Ophthalmol. 1960;50(6):1114-24.
Alka K, Casey JR. Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation. Invest Ophthalmol Vis Sci [Internet]. 2018 [cited 2020 Apr 18];59(10):4258-67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30140924
_______________________________________________________
Vanathi M, Panda A, Vengayil S, Chaudhuri Z, Dada T. Pediatric Keratoplasty. Surv Ophthalmol [Internet]. 2009 Mar [cited 2020 Apr 18];54(2):245-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19298903
_______________________________________________________
Mullaney PB, Risco JM, Teichmann K, Millar L. Congenital hereditary endothelial dystrophy associated with glaucoma. Ophthalmology [Internet]. 1995 Feb [cited 2020 Apr 18];102(2):186-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7862405
_______________________________________________________
Magli A, Capasso L, Foà T, Maurino V, Ventruto V. A further observation of corneal dystrophy and perceptive deafness in two siblings. Ophthalmic Genet [Internet]. 1997 Jun [cited 2020 Apr 18];18(2):87-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9228245
Downloads
Published
How to Cite
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
